Uday Baldota | Association for Accessible Medicines
THANK YOU - for all those who made our first-ever #GRxBiosims virtual conference a success.

Uday Baldota

AAM Board Member
Chief Executive Officer of Taro Pharmaceuticals, Sun Pharmaceutical Industries, Inc.
Uday Baldota
Uday Baldota
Sun Pharmaceutical Industries, Inc.

Uday Baldota serves as CEO of Taro Pharmaceuticals, of which Sun Pharmaceutical Industries is the parent company. He has over 20 years of management experience, a significant portion of which has been with Sun.

In addition to holding various leadership positions, Uday has been an integral part of Sun’s worldwide growth – including leading several important acquisitions and integrations, most recently that of Ranbaxy.

Uday has both an MBA from the Indian Institute of Management, Ahmedabad and a Chemical Engineering degree from the Indian Institute of Technology, Delhi.​

Latest Tweets

Association for Accessible Medicines


Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.